Price target upside
Barinthus Biotherapeutics plc - American Depositary Shares Price Target Upside or Downside
BRNS price target upside based on the current price and analyst average.
Direct answer
Barinthus Biotherapeutics plc - American Depositary Shares's analyst target implies +762.1%.
The average target is $5.00 compared with a recorded current price of $0.58.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Barinthus Biotherapeutics plc - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.58
- Average price target
- $5.00
- High price target
- $6.00
- Low price target
- $4.00
- Target upside
- +762.1%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026